Cytokinetics Inc (NASDAQ:CYTK)

During the Trading Day
7.00 +0.22 / +3.24%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.00 0.00 / 0.00%
 
Volume: 1.3K
Dyax's Hereditary Angioedema Drug Meets Primary Endpoint - Analyst Blog
7:21pm / Zacks.com
Novo Nordisk's Saxenda Gets EU Approval for Obesity - Analyst Blog
Mar 24 / Zacks.com
Intrexon-Merck KGaA Team Up for CAR-T Cancer Therapies - Analyst Blog
Mar 31 / Zacks.com
Eli Lilly Partners with Innovent to Develop Oncology Drugs - Analyst Blog
Mar 23 / Zacks.com
Amgen's Kyprolis Gets FDA Priority Review for Expanded Use - Analyst Blog
Mar 31 / Zacks.com
Celgene Presents Efficacy, Safety Data on Otezla - Analyst Blog
Mar 23 / Zacks.com
The Medicines Co.'s 3 Acute Care Drugs Approved in EU - Analyst Blog
Mar 31 / Zacks.com
Pfizer Reveals Detailed Xeljanz Data from Psoriasis Study - Analyst Blog
Mar 23 / Zacks.com
Horizon Pharma to Buy Hyperion Therapeutics for $1.1B - Analyst Blog
Mar 31 / Zacks.com
Sanofi Inks Multi-Component Strategic Deal with Evotec - Analyst Blog
Mar 20 / Zacks.com
Proteon Up on Positive Long-Term Data on its Candidate - Analyst Blog
Mar 30 / Zacks.com
Eli Lilly Collaborates with Korean Hanmi Pharmaceutical - Analyst Blog
Mar 20 / Zacks.com
Heat Biologics Posts Wider Loss Y/Y, Focus on Pipeline - Analyst Blog
Mar 30 / Zacks.com
Theravance/Glaxo's Breo Ellipta Gets Mixed FDA Panel View - Analyst Blog
Mar 20 / Zacks.com
Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog
Mar 27 / Zacks.com
Prothena's PRX002 Positive in Parkinson's Disease Study - Analyst Blog
Mar 20 / Zacks.com
Conatus Soars on Positive Phase II Data on Emricasan - Analyst Blog
Mar 27 / Zacks.com
Coronado Biosciences Jumps on Agreement with NeuPharma - Analyst Blog
Mar 20 / Zacks.com
Immune Design Starts Dosing Patients in CMB305 Study - Analyst Blog
Mar 27 / Zacks.com
Celgene's Data on Crohn's Disease Candidate Published - Analyst Blog
Mar 19 / Zacks.com
Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog
Mar 26 / Zacks.com
Vertex's Kalydeco Gets FDA Nod for Additional Indication - Analyst Blog
Mar 19 / Zacks.com
Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
Mar 26 / Zacks.com
Retrophin Soars on FDA Approval of Bile Acid Disorder Drug - Analyst Blog
Mar 19 / Zacks.com
Oncolytics' Cancer Drug Reolysin Gets Orphan Status in EU - Analyst Blog
Mar 26 / Zacks.com
Lexicon-Ipsen Agreement Expanded to Include Canada - Analyst Blog
Mar 19 / Zacks.com
Medivation-Astellas' Xtandi Positive in Prostate Cancer Study - Analyst Blog
Mar 26 / Zacks.com
Juno Therapeutics' (JUNO) Q4 Loss Wider than Expected - Analyst Blog
Mar 19 / Zacks.com
Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog
Mar 24 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account